Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- NIH programs aim to shed light on, optimize care for pancreatic diabetes Michael Monostra
-
- Ferdinand: New agents, devices ‘not enough’ to address hypertension care disparities Regina Schaffer
- Fracture rates similar between adults with Graves’ disease and general population Michael Monostra
- Joint statement calls for FDA to require drug trials to include people with obesity
- No HbA1c improvements for adults with type 2 diabetes exclusively using telemedicine Michael Monostra
- Obesity management, teplizumab guidance among updates in ADA 2024 Standards of Care Michael Monostra
- Once-daily JAK inhibitor helps preserve beta-cell function in type 1 diabetes Michael Monostra
- ‘People voted with their clicks’: Automated referrals boosted statin prescriptions Regina Schaffer
- PFAS endocrine-disrupting chemicals linked to higher odds of thyroid cancer Michael Monostra
-
- Polygenic risk score incorporating rare variants does not improve fracture prediction Michael Monostra
- Small HDL particles in brain appear protective against Alzheimer’s disease Scott Buzby
- Teprotumumab reduces proptosis in long-standing, stable thyroid eye disease Michael Monostra
- Use ‘more precise’ CVD risk scores to target therapy intensity for people with diabetes Regina Schaffer
- Vitamin D supplement does not lower fracture risk among children with 25-(OH)D deficiency Michael Monostra
- What to know about using non-insulin agents in type 1 diabetes Susan Weiner, MS, RDN, CDN, CDCES, FADCES; Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP
- White House announces initiative to improve women’s health research Erin T. Welsh, MA
- Endocrinology Drug and Device Update
-